tetramethylpyrazine has been researched along with Eye Cancer, Retinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Ge, J; Tang, M; Wu, N; Xu, L; Yang, Y; Yu, K; Yu, N; Yuan, M; Zhang, J; Zhang, Z; Zhuang, J | 1 |
| Chen, S; Chen, X; Ge, J; Han, X; Qiu, J; Wu, C; Wu, N; Wu, Y; Yang, M; Yang, Y; Yu, K; Yu, N; Zhang, J; Zhuang, J | 1 |
2 other study(ies) available for tetramethylpyrazine and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Tetramethylpyrazine-mediated regulation of CXCR4 in retinoblastoma is sensitive to cell density.
Topics: Adolescent; Adult; Animals; Cell Line, Tumor; Child; Female; Humans; Male; Middle Aged; Neoplasm Proteins; Pyrazines; Rats; Receptors, CXCR4; Retinoblastoma | 2017 |
Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nuclear Respiratory Factor 1; Pyrazines; Receptors, CXCR4; Retinal Neoplasms; Retinoblastoma; Transcription, Genetic; Tumor Cells, Cultured; Vasodilator Agents; Xenograft Model Antitumor Assays | 2019 |